Provided by Tiger Trade Technology Pte. Ltd.

Precigen

7.20
-0.2400-3.23%
Post-market: 7.18-0.0200-0.28%19:30 EDT
Volume:4.41M
Turnover:31.74M
Market Cap:2.57B
PE:-6.73
High:7.50
Open:7.50
Low:7.10
Close:7.44
52wk High:7.50
52wk Low:2.99
Shares:356.51M
Float Shares:194.00M
Volume Ratio:0.64
T/O Rate:2.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0700
EPS(LYR):-1.3727
ROE:-837.08%
ROA:-18.14%
PB:58.91
PE(LYR):-5.24

Loading ...

Is Precigen’s (PGEN) New PAPZIMEOS J-Code Reframing Its Respiratory Growth Narrative?

Simply Wall St.
·
Apr 17

Precigen expects Q1 revenue to exceed $18 million on PAPZIMEOS momentum

Reuters
·
Apr 08

Precigen Expects Q1 Revenue to Surpass $18 Million Due to Strong Uptake of Recurrent Respiratory Papillomatosis Drug

MT Newswires Live
·
Apr 07

GUIDANCE: (PGEN) Precigen Expects Q1 Revenue to Exceed $18M, vs. FactSet Est of $20.8M

MT Newswires Live
·
Apr 07

Precigen sees ‘robust uptake’ in usage of Papzimeos since its launch

TIPRANKS
·
Apr 07

Major Insider Move at Precigen Stuns Market Watchers

TIPRANKS
·
Apr 01

Precigen director Randal J. Kirk disposes of $14M common shares

Reuters
·
Apr 01

Precigen CEO, CCO join H.C. Wainwright virtual fireside chat

Reuters
·
Mar 30

Discover Precigen And 2 Other Insider-Favored Growth Stocks

Simply Wall St.
·
Mar 27

Olaplex, Kodiak Sciences, Precigen And Other Big Stocks Moving Higher On Thursday

Benzinga_recent_news
·
Mar 26

Stock Track | ...

Stock Track
·
Mar 26

Precigen Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Mar 26

Precigen price target raised to $10 from $9 at H.C. Wainwright

TIPRANKS
·
Mar 26

Stock Track | Precigen Soars 13.87% in Pre-market on First Commercial Sales and Revenue Beat

Stock Track
·
Mar 26

Stock Track | Precigen Soars 16.77% in Night Session on First Commercial Sales and Positive Earnings Report

Stock Track
·
Mar 26

Precigen Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 26

Stocks to Watch: MillerKnoll, Worthington Steel, Navan, Precigen

Dow Jones
·
Mar 26

Precigen Shares Rise on First Drug Sales Report

Dow Jones
·
Mar 26

Stock Track | Precigen Soars 5.16% After-Hours on Revenue Beat and Strong Commercial Momentum for PAPZIMEOS

Stock Track
·
Mar 26

Precigen Q4 EPS $(0.01) Beats $(0.08) Estimate, Sales $4.565M Miss $8.286M Estimate

Benzinga Earnings
·
Mar 26